Page last updated: 2024-08-21

picolinamide and Leukemia, Myeloid, Acute

picolinamide has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atallah, G; Aycinena, A; Basham, S; Bellamacina, C; Burger, MT; Castillo, J; Chan, J; Chen, MY; Dai, Y; Ding, Y; Feucht, P; Fritsch, C; Garcia, PD; Ginn, E; Han, W; Holash, J; Huh, K; Kauffmann, A; Lambert, A; Lan, J; Langowski, JL; Lindvall, MK; Mathur, M; Muller, K; Nishiguchi, G; Pfister, E; Simmons, R; Tamez, V; Vanasse, KG; Wang, Y; Zang, R; Zavorotinskaya, T; Zhang, Y1

Other Studies

1 other study(ies) available for picolinamide and Leukemia, Myeloid, Acute

ArticleYear
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Tria
    Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21

    Topics: Amides; Animals; Cell Line, Tumor; Halogenation; Humans; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Picolinic Acids; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-pim-1

2015